Royal Fund Management’s AstraZeneca AZN Stock Holding History

Royal Fund Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-228	Closed	-$20K	–	176
2020 Q1	$20K	Hold	228	–	–	0.01%	292
2019 Q4	$22K	Hold	228	–	–	0.01%	322
2019 Q3	$20K	Hold	228	–	–	0.01%	327
2019 Q2	$18K	Hold	228	–	–	0.01%	331
2019 Q1	$18K	Sell	228 -11	-5%	-$867	0.01%	311
2018 Q4	$18K	Buy	239 +11	+5%	+$859	0.01%	273
2018 Q3	$18K	Hold	228	–	–	0.01%	283
2018 Q2	$15K	Hold	228	–	–	0.01%	308
2018 Q1	$15K	Hold	228	–	–	0.01%	302
2017 Q4	$15K	Hold	228	–	–	0.01%	317
2017 Q3	$15K	Hold	228	–	–	0.01%	270
2017 Q2	$15K	Hold	228	–	–	0.01%	241
2017 Q1	$14K	Hold	228	–	–	0.01%	244
2016 Q4	$12K	Buy	+228	New	+$12.9K	0.01%	241

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Royal Fund Management's AZN Position: Q2 2020 in Review

Royal Fund Management sold out of AstraZeneca (AZN) in Q2 2020, closing a stake of 228 shares — an estimated $20K sold.

Royal Fund Management first reported a position in AZN in Q4 2016 and held it in 14 quarters. The position peaked at $22K in Q4 2019. 669 funds tracked by Wall St. Rank hold AZN as of Q2 2020.

Royal Fund Management reported no remaining AstraZeneca position as of Q2 2020 after selling out during the quarter.
Royal Fund Management sold 228 AstraZeneca shares in Q2 2020, an estimated $20K.
Royal Fund Management first reported a position in AstraZeneca in Q4 2016 and held it in 14 quarters.
Royal Fund Management's AstraZeneca position peaked at $22K in Q4 2019.
669 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2020.

Based on Royal Fund Management's 13F filing for Q2 2020, filed 6 Aug 2020.